Search

everythinglearnresearchcommunity

for

Search:↓

A Cavalier King Charles Spaniel had both uveodermatological syndrome and alopecia areata, and treatment with ciclosporin helped regrow hair.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

A woman's complete hair loss condition improved after recovering from COVID-19.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

VKHD can include rare oral symptoms like discolored teeth.

Exosome-based therapies show promise for treating alopecia areata but need more research.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Improved oral hygiene and dietary changes can help manage black hairy tongue syndrome.

Baricitinib can help improve hair loss and skin color issues in people with Down syndrome.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Key proteins and potential drugs for treating alopecia areata were identified.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Early diagnosis and aggressive treatment are essential for managing Vogt-Koyanagi-Harada syndrome effectively.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Stem-cell therapy shows promise for skin conditions but needs more research.

Different types of PCOS need specific diagnosis methods and treatments.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

A 61-year-old Filipino man had a skin condition that looked like another disease, making diagnosis difficult.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

A rare hair regrowth pattern can occur in some people with alopecia areata.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.